News

Licence extension includes the use of Zytiga as a combination therapy along with prednisone or prednisolone to treat metastatic castration-resistant prostate cancer (mCRPC), in men who are asymptomatic

Featuring vanilla and strawberry flavours, Souvenaid product is a 125ml once-a-day drink, which includes a combination of nutrients that are naturally present in food. People living with Alzheimer’s

The company can perform bronchoalveolar lavage (BAL) using study participants from its database. The bronchoscopy suite enables Celerion to discover the expression and quantification of protein biomarkers within

The advancement of the compound into the pre-clinical development triggers an agreed milestone payment to Evotec, under the collaboration signed in March 2008. Evotec chief operating officer Dr

The company anticipates launching both the brands into mass market retailers in the first quarter of 2013. Inergetics CMO Jim Kras said, "The incorporation of our brands allows

According to the deal, BPC will provide manufacturing services and license proprietary fractionation and purification manufacturing process for Respiratory Syncytial Virus (RSV) intravenous immune globulin to ADMA. BPC

The novel inhibitor of the enzyme glutathione S-transferase P1 1,Telintra activates Jun kinase, which regulates cellular growth and differentiation of blood precursor cells. Telintra investigational agent is being

The study is designed to assess the safety and immunogenicity of the company’s vaccine in HIV-positive patients who can control infections using oral HIV drug medication. GeoVax president

STI president and chief executive officer Henry Ji said, "With the acquisition of the proprietary rights to the rIVIG technology, we now have access to a multi-billion dollar